Ocular Imaging With Spectral Domain Optical Coherence Tomography
- Conditions
- HealthyMyopiaHypermetropia
- Interventions
- Device: Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG)
- Registration Number
- NCT00926549
- Lead Sponsor
- Yonsei University
- Brief Summary
The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with various ocular diseases.
- Detailed Description
Assessment of macular thickness is important for the treatment and follow-up of a variety of ocular diseases. The introduction of optical coherence tomography (OCT) has enabled clinicians to reliably detect small changes in macular thickness and to quantitatively evaluate the efficacy of different therapeutic modalities. In this study using the spectral domain-OCT, we examined the variations of macular retinal thickness and macular volume in normal eyes and in eyes with various ocular diseases.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- normal eyes
- myopic eyes
- hypermetropic eyes
- systemic illness
- cataract
- previous ocular trauma or surgery(other than cataract surgery or refractive surgeries)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description spectral domain-OCT Spectral domain-OCT (Cirrus™ HD-OCT, Carl Zeiss Meditec AG) Spectral domain-OCT scanning performed.
- Primary Outcome Measures
Name Time Method macular retinal thickness and volume 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Yonsei University College of Medicine, Gangnam Severance Hospital
🇰🇷Seoul, Korea, Republic of